Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
Joshua Friedman(Icahn School of Medicine at Mount Sinai), Eli L. Diamond(Memorial Sloan Kettering Cancer Center), Katherine S. Panageas(Mayo Clinic), Jithma P. Abeykoon(Mayo Clinic), Randy Yeh(Presbyterian Hospital), Kseniya Petrova‐Drus(Memorial Sloan Kettering Cancer Center), Melissa Pulitzer(Memorial Sloan Kettering Cancer Center), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Gary A. Ulaner(Memorial Sloan Kettering Cancer Center), Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center), Klaus J. Busam(Memorial Sloan Kettering Cancer Center), Ronald S. Go(Mayo Clinic), Vaios Hatzoglou(Memorial Sloan Kettering Cancer Center), Benjamin H. Durham(Memorial Sloan Kettering Cancer Center), Anne S. Reiner(Memorial Sloan Kettering Cancer Center), Vedavyas Gannamani(John H. Stroger, Jr. Hospital of Cook County), Gaurav Goyal(University of Alabama at Birmingham), Ofer Shpilberg(Texas Oncology), Diana Morlote(University of Alabama at Birmingham), Marc K. Rosenblum(Memorial Sloan Kettering Cancer Center), Shiraz Fidai(John H. Stroger, Jr. Hospital of Cook County), Raajit K. Rampal(Memorial Sloan Kettering Cancer Center), Ryan Reddy(University of Southern California), Roei David Mazor(Assuta Medical Center), Veronica Rotemberg(Memorial Sloan Kettering Cancer Center), Oshrat Hershkovitz‐Rokah(Assuta Medical Center), Mariko Yabe(Memorial Sloan Kettering Cancer Center), Karen L. Rech(Mayo Clinic in Arizona), Jasmine H. Francis(Roche (Switzerland)), Maryam Zia(John H. Stroger, Jr. Hospital of Cook County), Mario E. Lacouture(Memorial Sloan Kettering Cancer Center)
Cited by 15
Related Papers
How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
|Nature Medicine|2019|2.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k